Zhang Lei portfolio, Q3 2025

HHLR Advisors (Hillhouse) · 13F for the quarter ending Sep 30, 2025

For Q3 2025, HHLR Advisors (Hillhouse) reported $4.1B across 33 US-listed positions, led by PDD (27.8%), BABA (14.4%) and FUTU (13.8%). Compared with its filing for Q2 2025, Zhang Lei opened 5 new positions, added to 4, reduced 4 and sold out of 8; 20 positions did not change.

The largest purchase was an addition to BABA ($382.5M); the largest sale, a reduction of FUTU ($186.8M).

Reported value
$4.1B
Positions
33
In the top 10
93%
Filed
Nov 14
2025

Key facts

13F portfolio value
$4.1BQ3 2025
Positions
33
Largest holding
PDD 27.8%
New positions
5
Sold out
8
Filed
Nov 14, 2025

Holdings as of (Q3 2025), filed with the SEC on . Changes are measured against the filing for Jun 30, 2025. Every tracked investor's Q3 2025 13F.

Bought and sold in Q3 2025

Zhang Lei: buys and sells in Q3 2025
StockMoveSharesSizeOf portfolio
Alibaba Group Holding LtdBABA▲ Added 186%+2.14M$382.5M9.35%
Baidu IncBIDU▲ New+1.64M$216.2M5.29%
PDD Holdings IncPDD▲ Added 23%+1.62M$213.6M5.22%
Futu Holdings LtdFUTU▼ Reduced 25%−1.07M$186.8M4.57%
NetEase IncNTES▼ Reduced 52%−872.86K$132.7M3.24%
WNS Holdings Ltdno ticker on file
▼ Sold out−1.53M$96.8M2.37%
JD.com IncJD▼ Sold out−2.28M$74.3M1.82%
KE Holdings IncBEKE▼ Reduced 43%−3.23M$61.4M1.50%
Full Truck Alliance CoYMM▲ New+4.07M$52.7M1.29%
Sea LtdSE▲ New+180.05K$32.2M0.79%
Vipshop Holdings LtdVIPS▼ Sold out−1.13M$17M0.42%
LI Auto IncLI▼ Sold out−620K$16.8M0.41%
Zto Express Cayman IncZTO▼ Sold out−671.39K$11.9M0.29%
Yatsen Holding LtdYSG▼ Reduced 20%−1.23M$11.1M0.27%
Kanzhun LimitedBZ▼ Sold out−576.34K$10.3M0.25%
MSCI IncMSCI▼ Sold out−2.01K$1.2M0.03%
GE AerospaceGE▲ Added 59%+3.74K$1.1M0.03%
Equinox Gold CorpEQX▲ New+80.5K$902.8K0.02%
Barrick Mining CorpB▲ New+25.4K$832.4K0.02%
Moodys CorpMCO▲ Added 17%+412$196.3K0.00%
Lakeshore Biopharma Co Ltdno ticker on file
▼ Sold out−75.18K$76.7K0.00%

Holdings at the quarter's end

Zhang Lei holdings, Q3 2025
#StockSectorShare of portfolioValueSharesReported priceHeldSince Q2 2025
1PDD Holdings IncPDD · SPONSORED ADSConsumer Discretionary27.8%$1.1B8.59M$132.176+ qtrs▲ Added 23%
2Alibaba Group Holding LtdBABA · SPONSORED ADSConsumer Discretionary14.4%$588M3.29M$178.736+ qtrs▲ Added 186%
3Futu Holdings LtdFUTU · SPON ADS CL AFinancials13.8%$563.2M3.24M$173.916+ qtrs▼ Reduced 25%
4Webull CorpBULL · ORD SHS—12.0%$489.3M33.08M$14.792 qtrsNo change
5Beone Medicines LtdONC · SPONSORED ADSHealth Care8.61%$352.4M1.03M$340.706+ qtrsNo change
6Baidu IncBIDU · SPON ADR REP ATechnology5.29%$216.2M1.64M$131.771 qtrNew
7Legend Biotech CorpLEGN · SPONSORED ADSHealth Care4.77%$195.2M5.98M$32.616+ qtrsNo change
8NetEase IncNTES · SPONSORED ADSTechnology2.94%$120.2M790.81K$151.996+ qtrs▼ Reduced 52%
9Arrivent Biopharma IncAVBP—2.02%$82.7M4.48M$18.456+ qtrsNo change
10KE Holdings IncBEKE · SPONSORED ADSReal Estate1.97%$80.5M4.24M$19.006+ qtrs▼ Reduced 43%
11Full Truck Alliance CoYMM · SPONSORED ADSTechnology1.29%$52.7M4.07M$12.971 qtrNew
12Yatsen Holding LtdYSG · SPONSORED ADS—1.08%$44.3M4.89M$9.066+ qtrs▼ Reduced 20%
13Sea LtdSE · SPONSORD ADS—0.79%$32.2M180.05K$178.731 qtrNew
14
Clearwater Analytics Holdingsno ticker on file · CL A
—0.60%$24.6M1.37M$18.022 qtrsNo change
15Cytek Biosciences IncCTKB—0.57%$23.1M6.66M$3.476+ qtrsNo change
16Novabridge BiosciencesNBP · SPONSORED ADS—0.55%$22.6M5.98M$3.786+ qtrsNo change
17Gossamer Bio IncGOSS—0.32%$13.1M4.97M$2.636+ qtrsNo change
18Maze Therapeutics IncMAZE—0.29%$11.9M457.54K$25.933 qtrsNo change
19Agora IncAPI · ADS—0.20%$8M2.1M$3.824 qtrsNo change
20Contineum Therapeutics IncCTNM · CL A—0.19%$7.9M669.34K$11.756+ qtrsNo change
21
Smart SH Global Ltdno ticker on file · ADS
—0.13%$5.3M3.95M$1.356+ qtrsNo change
22Sagimet Biosciences IncSGMT—0.12%$5M724.8K$6.866+ qtrsNo change
23Tuya IncTUYA · SPONSERED ADS—0.09%$3.9M1.56M$2.476+ qtrsNo change
24GE AerospaceGEIndustrials0.07%$3M10.04K$300.826+ qtrs▲ Added 59%
25Mogu IncMOGU · SPON ADS—0.07%$2.9M847.51K$3.436+ qtrsNo change
26
Bright Scholar ED Holdings Ltdno ticker on file · SPON ADS NEW
—0.05%$1.9M988.14K$1.956+ qtrsNo change
27Moodys CorpMCOFinancials0.03%$1.4M2.89K$476.486+ qtrs▲ Added 17%
28Pacific Biosciences of California IncPACB—0.03%$1.2M918.89K$1.286+ qtrsNo change
29Equinox Gold CorpEQXMaterials0.02%$902.8K80.5K$11.221 qtrNew
30Barrick Mining CorpBMaterials0.02%$832.4K25.4K$32.771 qtrNew
31Aligos Therapeutics IncALGS—0.02%$747.2K76.25K$9.806+ qtrsNo change
32Uxin LtdUXIN · SPONSORED ADS—0.00%$66.3K19.16K$3.466+ qtrsNo change
33Ridgetech IncRDGT · SHS NEW—0.00%$24.6K20.17K$1.226+ qtrsNo change

By sector

Zhang Lei portfolio by sector, Q3 2025
SectorShare of portfolioValuePositions
Consumer Discretionary42.1%$1.7B2
Financials13.8%$564.5M2
Health Care13.4%$547.5M2
Technology9.51%$389.2M3
Real Estate1.97%$80.5M1
Industrials0.07%$3M1
Materials0.04%$1.7M2
No sector on file19.1%$780.6M20

Questions and answers

What did Zhang Lei own in Q3 2025?

HHLR Advisors (Hillhouse)'s 13F for Q3 2025 lists 33 positions worth $4.1B. The largest: PDD (27.8%), BABA (14.4%), FUTU (13.8%), BULL (12.0%), ONC (8.6%).

What did Zhang Lei buy in Q3 2025?

The largest purchases, by the shares bought at the quarter-end price the filing implies: BABA (added, $382.5M), BIDU (new, $216.2M), PDD (added, $213.6M), YMM (new, $52.7M), SE (new, $32.2M), GE (added, $1.1M).

What did Zhang Lei sell in Q3 2025?

The largest sales: FUTU (reduced, $186.8M), NTES (reduced, $132.7M), WNS Holdings Ltd (sold out, $96.8M), JD (sold out, $74.3M), BEKE (reduced, $61.4M), VIPS (sold out, $17M).

When was this filing made?

HHLR Advisors (Hillhouse) filed its 13F for the quarter ending Sep 30, 2025 on Nov 14, 2025. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.

Learn

Cite this page

Funkfolio, “Zhang Lei portfolio, Q3 2025: HHLR Advisors (Hillhouse) 13F holdings”, data as of 14 November 2025. https://funkfolio.com/gurus/hillhouse/2025-q3

Underlying data: SEC EDGAR, Form 13F-HR of HHLR Advisors (Hillhouse) (CIK 1762304) for the period ending Sep 30, 2025.

Source: SEC EDGAR, Form 13F-HR for HHLR Advisors (Hillhouse) (CIK 1762304), period ending Sep 30, 2025, filed Nov 14, 2025. Changes compare share counts with the filing for Jun 30, 2025; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $4.1B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 6 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. Not a live portfolio and not advice.